Losartan Potassium API Market Report 2025 (Global Edition)

Global Losartan Potassium API Market Report 2025 Market Size Split by Type Outlook: (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), by Application Outlook: (Research Institut...

Losartan Potassium API Market Report Description

We have various report editions of Losartan Potassium API Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Losartan Potassium API Market Insights Video

Competitive Landscape of the Losartan Potassium API Market

Leading competitors in the fiercely competitive Losartan Potassium API market are concentrated on growing their production capacity, guaranteeing high-purity formulations, and adhering to strict regulatory requirements. Large producers like Teva Pharmaceutical, Mylan, and Sun Pharmaceuticals dominate the market. Still, rising competitors from China and India are gradually taking market share because of their lower costs. In order to satisfy rising global demand, pricing, quality assurance, and building robust supply chains are the main areas of competition.

Top Companies Market Share in Losartan Potassium API Industry: (In no particular order of Rank)

• Tecoland
• Dr. Reddys Laboratories
• Sinoway Industrial
• Jigs chemical
• Pharmaffiliates
• FCDA
• Hangzhou Anchuan Chemical Technology
• MOSINTER GROUP
• Chongqing Kerui
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Losartan Potassium API Market

Which Region Dominates the Losartan Potassium API Market in 2024?

According to Cognitive Market Research, North America currently dominates the Losartan Potassium API market, and the region is expected to have significant growth during the projected period. Due to the increasing rate of hypertension and cardiovascular illnesses in the region, North America is a major factor driving the growth of the losartan potassium API market. The market for antihypertensive drugs like Losartan is fueled by the U.S., in particular, where there is a large aging population and a rising prevalence of chronic illnesses. The rise of the industry is further aided by the existence of reputable pharmaceutical businesses and a strong emphasis on research and development for new drug formulations. The global market is still dominated by North American growth for Losartan Potassium APIs as a result of regulatory approvals for generic medications and increased healthcare spending.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Due to its huge population and rising rates of high blood pressure and cardiovascular disorders, the Asia Pacific region is expected to witness substantial growth in the Losartan Potassium API market. The demand for efficient antihypertensive treatments is increasing as a result of increased healthcare costs brought on by rapid urbanization, changing lifestyles, and rising disposable incomes. Furthermore, because of the region's affordable manufacturing capabilities, the production of generic drugs is increasing. Asia Pacific will be a key hub for the manufacturing and consumption of losartan potassium APIs in the upcoming years as a result of government measures to improve healthcare access and further promote market expansion.

The current report Scope analyzes Losartan Potassium API Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Losartan Potassium API

According to Cognitive Market Research, the global Losartan Potassium API market size was estimated at USD 1652.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 660.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Losartan Potassium API market with a market size of USD 521.43 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. In the US, the need for efficient treatment options like Losartan is driven by the large number of Americans who suffer from hypertension.
• The Canada Losartan Potassium API market had a market share of USD 79.31 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. In Canada, an aging population is more likely to develop hypertension, which calls for the use of drugs like Losartan.
• The Mexico Losartan Potassium API market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 60.14 million in 2024.

Europe Losartan Potassium API

According to Cognitive Market Research, the global Losartan Potassium API market size was estimated at USD 1652.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 495.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

• The United Kingdom Losartan Potassium API market had a market share of USD 83.27 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. In the UK, increased patient treatment seeking is a result of public health programs that increase awareness regarding hypertension.
• The France Losartan Potassium API market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 45.60 million in 2024.
• According to Cognitive Market Research, the German Losartan Potassium API market size was valued at USD 98.14 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In Germany, a robust pharmaceutical sector supports the manufacturing and marketing of high-quality APIs.
• The Italy Losartan Potassium API market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 42.63 million in 2024.
• The Russia Losartan Potassium API market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 76.83 million in 2024.
• The Spain Losartan Potassium API market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 40.64 million in 2024
• The Luxembourg Losartan Potassium API market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 15.37 million in 2024.
• The Portugal Losartan Potassium API market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 10.41 million in 2024.
• The Greece Losartan Potassium API market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 5.95 million in 2024.
• The Rest of Europe's Losartan Potassium API market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 76.83 million in 2024.

Asia Pacific Losartan Potassium API

According to Cognitive Market Research, the global Losartan Potassium API market size was estimated at USD 1652.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 380.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Losartan Potassium API market size was valued at USD 171.00 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Losartan Potassium API sales surged in China due to the need for losartan is being driven by the rise in hypertension cases brought on by rapid urbanization and lifestyle changes.
• The Japan Losartan Potassium API market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 52.44 million in 2024.
• The India Losartan Potassium API market had a market share of USD 45.60 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. In India, the market for generic drugs is growing, which makes losartan more accessible and reasonably priced.
• The South Korean Losartan Potassium API market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 38.00 million in 2024.
• The Australian Losartan Potassium API market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 19.76 million in 2024.
• The Southeast Asia Losartan Potassium API market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 26.22 million in 2024.
• The Rest of Asia Pacific Losartan Potassium API market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 26.98 million in 2024.

South America Losartan Potassium API

According to Cognitive Market Research, the global Losartan Potassium API market size was estimated at USD 1652.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 82.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Losartan Potassium API market size was valued at USD 35.36 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Losartan Potassium API flourished in Brazil because heart and lung diseases are becoming more common in Brazil, which is increasing the need for efficient treatments.
• Argentina's Losartan Potassium API market had a market share of USD 13.88 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. In Argentina, the demand for hypertension therapies is driven by government initiatives focused on enhancing heart health.
• Colombia Losartan Potassium API market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 7.35 million in 2024.
• Peru Losartan Potassium API market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 6.77 million in 2024.
• Chile's Losartan Potassium API market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 5.95 million in 2024.
• The Rest of Latin America's Losartan Potassium API market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 13.30 million in 2024.

Middle East Losartan Potassium API

According to Cognitive Market Research, the global Losartan Potassium API market size was estimated at USD 1652.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 33.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031..

• The GCC Countries Losartan Potassium API market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 14.14 million in 2024. Losartan Potassium API sales flourish in GCC countries due to the availability of pharmaceuticals, including losartan, which is improved by large investments in healthcare services and facilities.
• The Egypt Losartan Potassium API market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 3.47 million in 2024.
• The South Africa Losartan Potassium API market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 5.22 million in 2024. Losartan Potassium API sales flourished in South Africa due to the emphasis on addressing chronic illnesses in South Africa's healthcare policies makes Losartan more necessary.
• The Turkey Losartan Potassium API market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 2.84 million in 2024.
• The Nigeria Losartan Potassium API market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 3.47 million in 2024.
• The Rest of the MEA Losartan Potassium API market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 3.90 million in 2024.

Losartan Potassium API Market Analysis

How are Segments Performing in the Global Losartan Potassium API Market?

Losartan Potassium API Market Type Segment Analysis

According to Cognitive Market Research, min purity more than 99% is likely to dominate the Losartan Potassium API Market over the forecast period. The pharmaceutical industry's strict quality standards are what fuel the need for Losartan Potassium API with a minimum purity of more than 99%. In particular, high-purity APIs are essential for treating cardiovascular illnesses and hypertension while also guaranteeing the safety and effectiveness of pharmaceuticals. High purity standards are mandated by regulatory bodies to reduce contaminants that may have a negative impact on patient health. Manufacturers are concentrating on creating high-purity Losartan Potassium APIs to satisfy these growing needs and improve their market competitiveness as healthcare providers place an increased emphasis on patient safety and medication quality.

The min purity 98%-99% is the fastest-growing segment in the Losartan Potassium API Market. Because of its capacity to combine quality and affordability, the pharmaceutical sector has a considerable need for Losartan Potassium API with a minimum purity of 98% to 99%. This level guarantees the continued efficacy of the API in treating hypertension and associated cardiovascular problems, however, with fewer strictures than higher purity levels. Manufacturers frequently aim for this purity level to satisfy consumers on a budget and for generic formulations. The market for Losartan Potassium APIs within this purity range is anticipated to expand due to the growing demand from healthcare providers who are continuously looking for dependable and reasonably priced therapeutic choices.

{type_desc_end application_desc {application_desc_start}

Losartan Potassium API Market Application Segment Analysis

According to Cognitive Market Research, the pharmaceutical segment holds the largest share of the market. The pharmaceutical sector is the main user of Losartan Potassium API for the treatment of cardiovascular disorders and hypertension. It efficiently relaxes blood arteries as an Angiotensin II receptor blocker (ARB), lowering blood pressure and enhancing blood flow. In addition to treating hypertension, it also helps diabetic patients manage heart failure and preserve kidney function. Because of its adaptability, losartan is a crucial component in many formulations, such as oral solutions and tablets. The increased emphasis on cardiovascular health is driving the demand for Losartan Potassium API in the pharmaceutical industry.

In the Losartan Potassium API Market, the category of research institutions has been growing quickly. Research organizations are increasingly using the Losartan Potassium API for clinical investigations pertaining to cardiovascular disease and hypertension. Its effectiveness, safety, and possible advantages are being studied in a variety of populations, including individuals with comorbid conditions, including diabetes and chronic kidney disease. Pharmacological research is also being conducted on losartan to understand its processes and long-term effects better. To improve treatment outcomes, research institutes also investigate novel formulations and combination medicines. Losartan Potassium API is in high demand in the research sector due to the emphasis on expanding medical knowledge and enhancing patient care, which makes it easier to create novel therapeutic approaches.

{application_desc_end} tenth_seg_desc {tenth_seg_desc_start} Conclusion

• The global Losartan Potassium API market will expand significantly by 5.50% CAGR between 2024 and 2031.
• Strict regulatory requirements guaranteeing safety and effectiveness in the treatment of heart failure and high blood pressure are driving the need for Losartan Potassium API with a minimum purity of above 99%.
• Losartan Potassium API functions as an Angiotensin II receptor blocker, improving blood flow and lowering blood pressure, and is mostly used in pharmaceuticals to treat hypertension and heart failure.
• {tenth_seg_desc_end} 8th FAQ Frequently asked questions regarding the global Losartan Potassium API market {faq_start} {faq}What is the market size for the Losartan Potassium API market in 2024? {ans}The global market size for Losartan Potassium API in 2024 is USD 1652.2 million. {faq}What is the growth rate for the Losartan Potassium API market over the forecast period? {ans}The global Losartan Potassium API market is expected to grow with a CAGR of 5.50% over the projected period. {faq}Which is the leading region of the market for Losartan Potassium API? {ans}North America held a significant global Losartan Potassium API market revenue share in 2024. {faq}Which region is projected to detect the fastest growth in the Losartan Potassium API market over the forecast period? {ans}Asia-Pacific will witness the fastest growth of the global Losartan Potassium API market over the coming years. {faq}Which country will be leading in the Losartan Potassium API market in 2024? {ans}The US had the most significant global Losartan Potassium API market revenue share in 2024. {faq}What are the key drivers for the growth of the Losartan Potassium API market? {ans}The main driver of the growth of the Losartan Potassium API market is the need for APIs, which is being driven by the expanding healthcare infrastructure in developing regions and focus on preventive healthcare. {faq}Which is the significant Losartan Potassium API market segment by application? {ans}The pharmaceutical category dominates the market. {faq_end} 11th Regional Insights {north_america_meta_description_start} North America Losartan Potassium API market size will be USD 660.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031. North America has emerged as a prominent participant, and its sales revenue is estimated to reach USD 927.7 Million by 2031. This growth is mainly attributed to the growing demand for the pharmaceutical industry. {north_america_meta_description_end} {north_america_report_title_start} North America Losartan Potassium API market size will be USD 660.88 million in 2024. {north_america_report_title_end} {north_america_start}

  According to Cognitive Market Research, the global Losartan Potassium API market size was estimated at USD 1652.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 660.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

  • According to Cognitive Market Research, the US had a major share in the Losartan Potassium API market with a market size of USD 521.43 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. In the US, the need for efficient treatment options like Losartan is driven by the large number of Americans who suffer from hypertension.
  • The Canada Losartan Potassium API market had a market share of USD 79.31 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. In Canada, an aging population is more likely to develop hypertension, which calls for the use of drugs like Losartan.
  • The Mexico Losartan Potassium API market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 60.14 million in 2024.
  {north_america_end} {north_america_report_scope_start} North America controls the worldwide Losartan Potassium API market. The rising rates of hypertension and cardiovascular illnesses in North America are major factors driving the need for Losartan Potassium API in the pharmaceutical sector. Angiotensin II receptor blocker Losartan plays a critical part in the management of these illnesses as medical professionals concentrate on efficient therapy alternatives. Its accessibility and affordability have been further enhanced by regulatory support for generic formulations. Furthermore, its application across a variety of patient populations is strengthened by the move toward customized therapy and fixed-dose combinations. The pharmaceutical environment in North America is shaped in part by the increasing focus on treatment outcomes and patient adherence in the management of chronic diseases, which in turn drives ongoing demand for Losartan Potassium API. {north_america_report_scope_end} {europe_meta_description_start} Europe Losartan Potassium API market will be USD 495.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031. Patient compliance is increased by the creation of fixed-dose combinations containing losartan, which is expected to aid sales to USD 682.6 million by 2031 {europe_meta_description_end} {europe_report_title_start} Europe's Losartan Potassium API market will be USD 495.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031. {europe_report_title_end} {europe_start}

  According to Cognitive Market Research, the global Losartan Potassium API market size was estimated at USD 1652.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 495.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

  • The United Kingdom Losartan Potassium API market had a market share of USD 83.27 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. In the UK, increased patient treatment seeking is a result of public health programs that increase awareness regarding hypertension.
  • The France Losartan Potassium API market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 45.60 million in 2024.
  • According to Cognitive Market Research, the German Losartan Potassium API market size was valued at USD 98.14 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In Germany, a robust pharmaceutical sector supports the manufacturing and marketing of high-quality APIs.
  • The Italy Losartan Potassium API market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 42.63 million in 2024.
  • The Russia Losartan Potassium API market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 76.83 million in 2024.
  • The Spain Losartan Potassium API market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 40.64 million in 2024
  • The Luxembourg Losartan Potassium API market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 15.37 million in 2024.
  • The Portugal Losartan Potassium API market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 10.41 million in 2024.
  • The Greece Losartan Potassium API market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 5.95 million in 2024.
  • The Rest of Europe's Losartan Potassium API market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 76.83 million in 2024.
  {europe_end} {europe_report_scope_start} The European market is going to have a massive impact on the Losartan Potassium API market. Further, because of the increased prevalence of cardiovascular illnesses and hypertension in Europe, healthcare professionals are in greater demand for Losartan Potassium API. Losartan plays an increasingly important role as an Angiotensin II receptor blocker as healthcare systems focus on

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Losartan Potassium API Industry. Request a Free Sample PDF!

Losartan Potassium API Market Application Segment Analysis

According to Cognitive Market Research, the pharmaceutical segment holds the largest share of the market. The pharmaceutical sector is the main user of Losartan Potassium API for the treatment of cardiovascular disorders and hypertension. It efficiently relaxes blood arteries as an Angiotensin II receptor blocker (ARB), lowering blood pressure and enhancing blood flow. In addition to treating hypertension, it also helps diabetic patients manage heart failure and preserve kidney function. Because of its adaptability, losartan is a crucial component in many formulations, such as oral solutions and tablets. The increased emphasis on cardiovascular health is driving the demand for Losartan Potassium API in the pharmaceutical industry.

In the Losartan Potassium API Market, the category of research institutions has been growing quickly. Research organizations are increasingly using the Losartan Potassium API for clinical investigations pertaining to cardiovascular disease and hypertension. Its effectiveness, safety, and possible advantages are being studied in a variety of populations, including individuals with comorbid conditions, including diabetes and chronic kidney disease. Pharmacological research is also being conducted on losartan to understand its processes and long-term effects better. To improve treatment outcomes, research institutes also investigate novel formulations and combination medicines. Losartan Potassium API is in high demand in the research sector due to the emphasis on expanding medical knowledge and enhancing patient care, which makes it easier to create novel therapeutic approaches.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Manoj Phagare

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals 
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.

Author's Conclusion